4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-21-015274
Options or other derivatives
- CEO and President acquired 323,635 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KLEMP WALTER V · CEO and President
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-16 | Grant or award : show line 1 in the form Stock option (right to buy) | +223,635 | 628,785 | D |
| 2021-06-16 | Grant or award : show line 2 in the form Restricted Stock Units | +100,000 | 728,785 | D |
Loading xslF345X03/rdgdoc.xml…